Ômega-3: o que existe de concreto? - Nutritotal

Ebel JG Jr, Eckerlin RH, Maylin GA, Gutenmann WH, Lisk DJ. PolychlorinatedBiphenyls and p,p’-DDE in Encapsulated Fish Oil Supplements. Nutr Rept Int.1987;36:413-7.Elson CO. Genes, microbes, and T cells--new therapeutic targets in Crohn’sdisease. N Engl J Med. 2002;346(8):614-6.Endres S, Lorenz R, Loeschke K. Lipid treatment of inflammatory boweldisease. Curr Opin Clin Nutr Metab Care. 1999;2(2):117-20.Engler MM, Engler MB. Omega-3 fatty acids: role in cardiovascular health anddisease. J Cardiovasc Nurs. 2006;21(1):17-24, quiz 25-6.Food and Nutrition Information Center. Dietary Reference Intakes:Macronutrients. Disponível em:http://www.iom.edu/Object.File/Master/7/300/0.pdf. Acessado em 28/11/2005.Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietaryrecommendations and food sources to achieve essentiality and cardiovascularbenefits. Am. J. Clin. Nutr. 2006 Jun;83(6 Suppl):1526S-1535S.Grimminger F, Mayser P, Papavassilis C, et al. A double-blind, randomized,placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extendedguttate psoriasis. Rapid improvement of clinical manifestations and changes inneutrophil leukotriene profile. Clin Investig. 1993;71(8):634-43.Grimminger F, Mayser P. Lipid mediators, free fatty acids and psoriasis.Prostaglandins Leukot Essent Fatty Acids. 1995;52(1):1-15.Grimsgaard S, Bonaa KH, Hansen JB, Nordøy A. Highly purifiedeicosapentaenoic acid and docosahexaenoic acid in humans have similartriacylglycerol-lowering effects but divergent effects on serum fatty acids. Am JClin Nutr. 1997;66(3):649-59.Guallar E, Sanz-Gallardo MI, van’t Veer P, et al. Mercury, fish oils, and the riskof myocardial infarction. N Engl J Med. 2002;347(22):1747-54.Guezennec CY, Nadaud JF, Satabin P, Leger F, Lafargue P. Influence ofpolyunsaturated fatty acid diet on the hemorrheological response to physicalexercise in hypoxia. Int J Sports Med. 1989;10(4):286-91.Harris WS, Reid KJ, Sands SA, Spertus JA. Blood omega-3 and trans fattyacids in middle-aged acute coronary syndrome patients. Am J Cardiol. 200715;99(2):154-8.Harris WS. Are omega-3 fatty acids the most important nutritional modulators ofcoronary heart disease risk? Curr Atheroscler Rep. 2004;6(6):447-52.33